MedTrace Logo

Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients

NCT06882551 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2025-03-18

No results posted yet for this study

Summary

Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema

Conditions

  • Diabetic Macular Edema (DME)

Interventions

DRUG

Intravitreal Bevacizumab IVB

Intravitreal bevacizumab alone

DRUG

intravitreal bevacizumab and suprachoroidal triamcinolone acetonide

Combination of Intravitreal bevacizumab and suprachoroidal triamcinolone acetonide

Sponsors & Collaborators

  • Khyber Teaching Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
32 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-11-30
Completion
2024-01-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06882551 on ClinicalTrials.gov